BAP1 and nonpapillary renal cell carcinoma: Several large-scale clinical genomic profiling has shown the presence of a large number of chromatin modifier genes in ccRCCs, including PBRM1, SETD2, BAP1, KDM5C, and MLL225, 26, but none of them is associated with the characteristic metabolic phenotypes of ccRCC.